scholarly article | Q13442814 |
P356 | DOI | 10.1002/CNCY.20168 |
P698 | PubMed publication ID | 21717592 |
P2093 | author name string | Josep Lloreta | |
Francesc Solé | |||
Marta Salido | |||
Blanca Espinet | |||
Antoni Gelabert-Mas | |||
José Placer | |||
Lara Pijuan | |||
Ana B Galván | |||
Núria Juanpere | |||
P2860 | cites work | Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study | Q34361348 |
The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer | Q36964427 | ||
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder | Q37158767 | ||
Bladder cancer biomarkers and their role in surveillance and screening | Q37361497 | ||
Flourescence cystoscopy--how to do it. | Q37438866 | ||
A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis | Q37781786 | ||
The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine | Q42721217 | ||
Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy | Q44505075 | ||
Bladder cancer: epidemiology, staging and grading, and diagnosis. | Q45247416 | ||
UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing | Q45374139 | ||
A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy | Q46648283 | ||
Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization. | Q53628297 | ||
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma | Q73062815 | ||
The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer | Q76352148 | ||
Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology | Q78644394 | ||
Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings | Q79517685 | ||
The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer | Q80206379 | ||
The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer | Q81204170 | ||
Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice | Q81479508 | ||
Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology | Q81505387 | ||
Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples | Q81637608 | ||
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer | Q83216597 | ||
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy | Q83381017 | ||
Reflex UroVysion testing in suspicious urine cytology cases | Q83612735 | ||
P433 | issue | 6 | |
P304 | page(s) | 395-403 | |
P577 | publication date | 2011-06-29 | |
P1433 | published in | Cancer Cytopathology | Q13452937 |
P1476 | title | A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study | |
P478 | volume | 119 |
Q36340124 | A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection |
Q37435097 | Diagnosis of bladder cancer from the voided urine specimens using multi-target fluorescence in situ hybridization |
Q60302268 | Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma |
Q37238810 | Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation |
Q37705271 | Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy |
Q92487538 | Significant lack of urine-based biomarkers to replace cystoscopy for the surveillance of non-muscle invasive bladder cancer |
Q35147519 | Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer |
Q45139625 | Urine cytology - update 2013. A systematic review of recent literature |
Q91756608 | Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients |
Q53572489 | [Non-muscle-invasive high-grade bladder cancer]. |
Search more.